ClinConnect ClinConnect Logo
Search / Trial NCT05138783

Clinical Performance of Two Daily Disposable Soft Contact Lenses

Launched by ALCON RESEARCH · Nov 15, 2021

Trial Information

Current as of August 28, 2025

Completed

Keywords

Contact Lenses

ClinConnect Summary

Subjects will be expected to attend 3 visits. Subjects will be expected to wear their study contact lenses every day for at least 10 hours per day over an 8-day period for each study lens type. The total duration of a subject's participation in the study will be up to 22 days.

Gender

ALL

Eligibility criteria

  • Key Inclusion Criteria:
  • Successful wear of spherical soft contact lenses with at least 3 months wearing experience, with a minimum wearing time of 5 days per week and 10 hours per day.
  • Willing to wear habitual spectacles for vision correction when study lenses are not worn, as needed.
  • Willing to wear contact lenses for at least 16 hours on the day prior to Visit 2 and the day prior to Visit 3.
  • Other protocol-defined inclusion criteria may apply.
  • Key Exclusion Criteria:
  • Participation in a clinical trial within the previous 30 days or currently enrolled in any clinical trial.
  • Habitual PRECISION1, Biotrue, and DAILIES TOTAL1 contact lens wear.
  • Monovision and multifocal lens wear.
  • Other protocol-defined exclusion criteria may apply.

About Alcon Research

Alcon Research is a leading global company dedicated to advancing eye care through innovative research and development. As a subsidiary of Novartis, Alcon focuses on the development of cutting-edge products and therapies for vision correction and eye health, including surgical, pharmaceutical, and consumer eye care solutions. With a commitment to enhancing the quality of life for patients worldwide, Alcon Research conducts rigorous clinical trials to evaluate the safety and efficacy of its products, ensuring that they meet the highest standards of care. Through collaboration with healthcare professionals and institutions, Alcon remains at the forefront of ophthalmic advancements, driving progress in the field of vision science.

Locations

Medina, Minnesota, United States

Shawnee Mission, Kansas, United States

Tallahassee, Florida, United States

Maitland, Florida, United States

Medina, Minnesota, United States

Granville, Ohio, United States

Wichita Falls, Texas, United States

Tallahassee, Florida, United States

Franklin Park, Illinois, United States

Shawnee Mission, Kansas, United States

Wichita Falls, Texas, United States

Weston, Wisconsin, United States

Maitland, Florida, United States

Granville, Ohio, United States

Franklin Park, Illinois, United States

Weston, Wisconsin, United States

Patients applied

0 patients applied

Trial Officials

Clinical Trial Lead, Vision Care

Study Director

Alcon Research, LLC

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials